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Food manufacturers have a fundamental responsibility to guarantee 
the safety of their products prior to resale.  Novel food items, food 
ingredients and genetically modified (GM) crops must pass detailed 
pre-market risk assessment checks prior to market release to provide 
assurances that, given particular conditions of exposure, they do not 
pose any risk for human health, animal health or the environment.  
Because of their history of safe use, traditional food items serve as 
the baseline for comparisons of safety for novel or GM foods within 
the principle of substantial equivalence.   
The government has a duty to protect public health, and reports of 
ill health associated with intakes of any foodstuff are acted on without delay.  In the case of novel and GM 
foods and food ingredients, potential safety hazards must be considered because they have either never 
before been used as a food, result from a process that has not previously been used for food or have been 
modified by genetic manipulation.  New legislative recommendations are consequently being established 
to help ensure that such products are also monitored post-market to ensure anticipated consumption levels 
are accurate, and that they are not associated with unexpected side effects (Regulation (EC) No 1829/2003 
22 September 2003).  
2. Why is post-market monitoring necessary? 
The UK Food Standards Agency 'Consumer views of GM food' report (Food Standards Agency 2003) 
testified that despite recognition among consumers that GM foods have been consumed outside the EU for 
a number of years without suggestion of associated health problems, concerns regarding the potential long-
term health effects of eating GM food remain.  Failures by government officials to learn from cases such 
as the Escherichia coli (E. coli) O157 outbreak in Central Scotland and BSE in cattle have amplified 
distrust of science and government, and as a result, consumers have made increased demands for scientific 
certainty.  To endorse findings from pre-market risk assessment checks, assurances for consumer safety 
are sought via post-market monitoring.  The objectives of such are to:  
 Ensure that no health issues are associated with over consumption of specific ingredients  
 Determine what risks are apparent if intakes of novel foods interact with other nutrients and/or drugs  
 Establish longer term effects associated with recommended and observed intake levels  
 Assess risks associated with consumption in specific population groups (e.g. pregnant women, 
children)  
3. What should post-market monitoring address? 
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Pre-market risk assessment checks are insufficiently complex to determine exactly who will consume 
marketed products, how much of a product will be consumed post-release, and whether unpredicted side 
effects will result among ‘at risk’ population groups such as children, pregnant women or allergic 
individuals or after prolonged exposure.  This has resulted in three questions of particular interest to 
scientists considering post-market monitoring (Wal et al. 2003): 
3.1 Is the product use as predicted/recommended? 
Assessing dietary intake using any method is subject to uncertainties.  Collection of sales or purchase data, 
for example, may provide only data on foods purchased for consumption within the home, while reliance 
on participants’ memories for dietary diary or recall data leaves such collection methods open to 
misreporting biases (Robertson et al. 2004). Where intakes of novel food items with altered nutritional 
composition, nutritional value or specific health claims are of interest, consumption levels may be elevated 
above that estimated using a traditional counterpart and compositional information may be less accessible 
than that for traditional products.  Assessing intakes of composite food items will be easier than tracing 
ingredients contained within a number of different products in differing concentrations, however data 
collection will remain open to potential misreporting biases.  It is essential that precise intake data is 
collected to confirm absence of adverse side effects at true consumer exposure levels, and that dietary 
assessment data is sufficiently detailed to enable an assessment of food, nutrient and drug interaction 
effects to be made. 
3.2 Are the known side effects as predicted? 
The utility of post-market monitoring is not to confirm the beneficial effects under which claims novel 
foods are marketed, but to quantify true exposure levels and observe any adverse effects highlighted in the 
pre-market risk assessment checks to ensure they do not have any significant impact on health outcomes.  
This requires that any post-market monitoring campaign assesses novel food items on a case-by-case basis, 
addressing possible side effects noted in the pre-market risk assessment. 
3.3 Does the product cause unexpected side effects? 
Without regulated post-market monitoring of novel food intakes, unintended side effects are generally 
observed by food manufacturers using a passive signalling system detailing consumer complaints reported 
via consumer care lines.  This method is potentially biased as it requires the consumer to attribute their 
symptoms to a certain product.  As ‘unintended’ side effects could include any number of health outcomes 
(e.g. gastric, allergenic or chronic outcomes such as cancer), post-market monitoring campaigns must be 
all encompassing.  To address the financial restrictions imposed by such a system, novel foods requiring 
post-market monitoring must be assessed on a case-by-case basis, and the scope of the methodology 
influenced by the findings of the pre-market safety checks. 
4. How should post-market monitoring be completed? 
There do not appear to be any specific systems in place across the 
world to monitor long term intakes of novel food items post-market 
and concerns exist surrounding the real feasibility of conducting 
post-market monitoring.  The UK Food Standards Agency has 
commissioned one of the only feasibility studies to be completed so 
far (Elliott et al. 2003; Robertson et al. 2004).  This project used ten 
years of commercially available food purchase data, and traced 
household composition, regional and temporal disparities in 
purchase patterns for 4 groups of ‘marker foods’.  This research 
group highlighted extensive modifications necessary to the database before it could feasibly be used for 
post-market surveillance; for example, additional information on foods consumed outside the home, and a 
direct linkage system between product barcodes and ingredient/nutrient composition information would be 
required.  This project did not attempt to link food purchase data with health data, and ultimately 
concluded that surveillance of food intakes must be prospective to enable eventual linkage with putative 
health effects (Elliott et al. 2003).  
In Australia, the Australia New Zealand Food Authority (ANZFA) has described their use of a dietary 
modelling system to predict consumption of complete novel foods or chemicals within such products.  
This relies on the pre-market risk assessment estimate of intake (i.e. that all equivalent ‘traditional’ foods 
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are replaced with the novel food) being true.  This system combines estimated exposure data (collated 
from available food consumption and nutrient, additive, contaminant and agricultural chemical residue 
concentration data) and reference health standards data where available, for the complete population and 
specific population subgroups.  However, it has not yet been used to complete post-market monitoring of 
novel foods, therefore, its true feasibility is not yet certain (Organization for Economic Co-operation and 
Development 2003). 
5. Looking ahead 
Although the necessity for post-market monitoring of novel and GM foods and food ingredients is well 
justified, guidance does not go far enough in terms of practical advice.  Consumer groups are seldom 
accurately definable, traceability from raw ingredients to finished products is not straightforward, and the 
causal chain from ingestion of foods and/or ingredients to health effects is not clear cut.  Post-market 
monitoring must address issues of importance to manufacturers, consumers, health professionals and the 
government.  The ideal methodology under which to conduct post-market monitoring is not yet known.   
Post-market monitoring efforts are underway to establish who is consuming phytosterol ester-containing 
spreads, thus determining whether these are reaching the target consumer group or are being consumed by 
non-target consumers (Organization for Economic Co-operation and Development 2003).  Although this 
cannot be considered long-term monitoring and although it is unlikely to capture all relevant health 
outcome data, this work is an important first step.  Scientists await the results of this work optimistically, 
encouraged that they will inform the increasingly complex and problematic research question “How best 
should we conduct post-market monitoring?” 
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